Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GCIG Rustin Ovarian Cancer 2011 Oncology Response Criteria

Known as: GCIG RUSTIN OVARIAN CANCER 2011 
Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
This article charts the trip made by civil rights leader Bayard Rustin to West Africa in 1952 and examines the unpublished Africa… Expand
2016
2016
BACKGROUND Randomized, phase III trial to evaluate safety and efficacy of topotecan and carboplatin (TC) compared with standard… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
2014
2014
update. Eur Urol 2011; 60: 304–319. 18. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology for… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
2014
2014
  • P. Casali
  • Annals of oncology : official journal of the…
  • 2014
  • Corpus ID: 206319844
1. Calvert AH, Harland SJ, Newell DR et al. Early clinical studies with cis-diammine1,1-cyclobutane dicarboxylate platinum II… Expand
2013
2013
Vow-Taking on the Tibetan Plateau In Tibetan areas of the PRC, a new movement to assert Buddhist ethics is gaining momentum… Expand
2012
2012
Background:CA-125 as a tumour progression criterion in relapsing ovarian cancer (ROC) trials remains controversial. CALYPSO is a… Expand
  • table 1
  • figure 1
  • table 3
  • table 2
2010
2010
www.thelancet.com Vol 375 January 23, 2010 281 1 Katsumata N, Yasuda M, Takahashi F, et al. Dose-dense paclitaxel once a week in… Expand
2007
2007
There has been a revolution in our understanding of intersubjectivity. This revolution has many roots. Three findings of special… Expand
  • figure 1
  • figure 1
  • figure 2
  • figure 3